Intranasal nerve growth factor attenuates tau phosphorylation in brain after traumatic brain injury in rats

Journal of the Neurological Sciences

Volumn 345, Issue 1, 2014, Pages 48-55

  Lv, Qiushi ^a   Lan, Wenya ^a   Sun, Wenshan ^a   Ye, Ruidong ^a   Fan, Xiaobing ^a   Ma, Minmin ^a   Yin, Qin ^a   Jiang, Yongjun ^a   Xu, Gelin ^a   Dai, Jianwu ^b   Guo, Ruibing ^a   Liu, Xinfeng ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

GSK 3 ; IL 1 ; Intranasal; Nerve growth factor; Tau; Traumatic brain injury

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; PYRROLIDINE DITHIOCARBAMATE; TAU PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MESSENGER RNA; NUCLEAR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CONTUSION; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; BRAIN INJURIES; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; INTRANASAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TIME;

ADMINISTRATION, INTRANASAL; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN-1BETA; MALE; NERVE GROWTH FACTOR; NUCLEAR PROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TAU PROTEINS; TIME FACTORS;

EID: 84908150889     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.06.037     Document Type: Article

References (44)

1. A.A. Hyder, C.A. Wunderlich, P. Puvanachandra, G. Gururaj, and O.C. Kobusingye The impact of traumatic brain injuries: a global perspective NeuroRehabilitation 22 2007 341 353
2. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, and V. Aboyans Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2013 2095 2128
3. S.T. DeKosky, M.D. Ikonomovic, and S. Gandy Traumatic brain injury - football, warfare, and long-term effects New Engl J Med 363 2010 1293 1296
4. B.E. Gavett, R.A. Stern, R.C. Cantu, C.J. Nowinski, and A.C. McKee Mild traumatic brain injury: a risk factor for neurodegeneration Alzheimers Res Ther 2 2010
5. P. Calissano, C. Matrone, and G. Amadoro Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease Dev Neurobiol 70 2010 372 383
6. B.J. Williams, M. Eriksdotter-Jonhagen, and A.C. Granholm Nerve growth factor in treatment and pathogenesis of Alzheimer's disease Prog Neurobiol 80 2006 114 128
7. D. Albeck, M.H. Mesches, S. Juthberg, M. Browning, P.C. Bickford, and G.M. Rose Exogenous NGF restores endogenous NGF distribution in the brain of the cognitively impaired aged rat Brain Res 967 2003 306 310
8. S. Capsoni, S. Giannotta, and A. Cattaneo Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice Proc Natl Acad Sci U S A 99 2002 12432 12437
9. X.Y. Fan, Y. Li, M.M. Ma, R.B. Guo, G.L. Xu, and X.F. Liu Intranasal dosing of nerve growth factor protects brain from poisoning of organophosphorus compounds in rats Zhonghua Yi Xue Za Zhi 92 2012 2366 2369
10. Y. Jiang, N. Wei, T. Lu, J. Zhu, G. Xu, and X. Liu Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats Neuroscience 172 2011 398 405
11. Y. Jiang, J. Zhu, G. Xu, and X. Liu Intranasal delivery of stem cells to the brain Expert Opin Drug Deliv 8 2011 623 632
12. Q. Lv, X. Fan, G. Xu, Q. Liu, L. Tian, and X. Cai Intranasal delivery of nerve growth factor attenuates aquaporins-4-induced edema following traumatic brain injury in rats Brain Res 1493 2013 80 89
13. R. Guo, L. Tian, Q. Lv, X. Fan, and X. Liu Intranasal delivery of nerve growth factor for cognitive dysfunction after traumatic brain injury in rats J Med Postgrad 5 2012 471 475
14. L.L. Tian, R.B. Guo, X.Y. Yue, Q.S. Lv, X.C. Ye, and Z.Z. Wang Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats Brain Res 1440 2012 47 55
15. R. Medeiros, D. Baglietto-Vargas, and F.M. LaFerla The role of tau in Alzheimer's disease and related disorders CNS Neurosci Ther 17 2011 514 524
16. D.G.E. Montejo, L. Serrano, and J. Avila Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease Biochem Biophys Res Commun 141 1986 790 796
17. E. Kopke, Y.C. Tung, S. Shaikh, A.C. Alonso, K. Iqbal, and I. Grundke-Iqbal Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease J Biol Chem 268 1993 24374 24384
18. E. Mandelkow, M. von Bergen, J. Biernat, and E.M. Mandelkow Structural principles of tau and the paired helical filaments of Alzheimer's disease Brain Pathol 17 2007 83 90
19. M.J. Metcalfe, and M.E. Figueiredo-Pereira Relationship between tau pathology and neuroinflammation in Alzheimer's disease Mt Sinai J Med 77 2010 50 58
20. D.M. Feeney, M.G. Boyeson, R.T. Linn, H.M. Murray, and W.G. Dail Responses to cortical injury 1. Methodology and local-effects of contusions in the rat Brain Res 211 1981 67 77
21. X.F. Liu, J.R. Fawcett, R.G. Thorne, T.A. DeFor, and W.H. Frey Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage J Neurol Sci 187 2001 91 97
22. R. Ye, Q. Yang, X. Kong, N. Li, Y. Zhang, and J. Han Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition Crit Care Med 40 2012 2685 2693
23. R. Ye, X. Zhang, X. Kong, J. Han, Q. Yang, and Y. Zhang Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia Neuroscience 178 2011 169 180
24. Y. Jiang, N. Wei, J. Zhu, T. Lu, Z. Chen, and G. Xu Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of rat Mediators Inflamm 2010 2010 372423
25. X. Ye, M. Chopp, X. Liu, A. Zacharek, X. Cui, and T. Yan Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats Neuroscience 190 2011 339 345
26. F.S. Yu, Y.M. Zhang, and D.M. Chuang Lithium reduces BACE1 overexpression, beta amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury J Neurotrauma 29 2012 2342 2351
27. H. Forstl, C. Haass, B. Hemmer, B. Meyer, and M. Halle Boxing-acute complications and late sequelae from concussion to dementia Dtsch Arztebl Int 107 2010 818 835
28. J.E. Greer, J.T. Povlishock, and K.M. Jacobs Electrophysiological abnormalities in both axotomized and nonaxotomized pyramidal neurons following mild traumatic brain injury J Neurosci 32 2012 6682 6687
29. M.D. Ikonomovic, K. Uryu, E.E. Abrahamson, J.R. Ciallella, J.Q. Trojanowski, and V. Lee Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury Exp Neurol 190 2004 192 203
30. J.J. Lucas, F. Hernandez, P. Gomez-Ramos, M.A. Moran, R. Hen, and J. Avila Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice EMBO J 20 2001 27 39
31. M. Obulesu, R. Venu, and R. Somashekhar Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology Neurochem Res 36 2011 1329 1335
32. H. Yamaguchi, K. Ishiguro, T. Uchida, A. Takashima, C.A. Lemere, and K. Imahori Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II Acta Neuropathol 92 1996 232 241
33. P.L. McGeer, and E.G. McGeer NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies Neurobiol Aging 28 2007 639 647
34. M. Kitazawa, S. Oddo, T.R. Yamasaki, K.N. Green, and F.M. LaFerla Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J Neurosci 25 2005 8843 8853
35. Y. Li, L. Liu, S.W. Barger, and W.S. Griffin Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway J Neurosci 23 2003 1605 1611
36. K. Sriram, and J.P. O'Callaghan Divergent roles for tumor necrosis factor-alpha in the brain J Neuroimmune Pharmacol 2 2007 140 153
37. J. Zhu, Y. Jiang, L. Wu, T. Lu, G. Xu, and X. Liu Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia Neuroscience 202 2012 342 351
38. V. Fridmacher, B. Kaltschmidt, B. Goudeau, D. Ndiaye, F.M. Rossi, and J. Pfeiffer Forebrain-specific neuronal inhibition of nuclear factor-kB activity leads to loss of neuroprotection J Neurosci 23 2003 9403 9408
39. J. Gotz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
40. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, and G. Jones Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 2001 1487 1491
41. H.T. Tran, F.M. LaFerla, D.M. Holtzman, and D.L. Brody Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities J Neurosci 31 2011 9513 9525
42. A.C. McKee, R.C. Cantu, C.J. Nowinski, E.T. Hedley-Whyte, B.E. Gavett, and A.E. Budson Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury J Neuropathol Exp Neurol 68 2009 709 735
43. K.A. Vossel, K. Zhang, J. Brodbeck, A.C. Daub, P. Sharma, and S. Finkbeiner Tau reduction prevents Abeta-induced defects in axonal transport Science 330 2010 198
44. L.K. Clinton, M. Blurton-Jones, K. Myczek, J.Q. Trojanowski, and F.M. LaFerla Synergistic interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline J Neurosci 30 2010 7281 7289